Genotyping of NED prostate cancer revealed gene amplifications found significantly higher than non-NED prostate cancer, AURKA and MYCN. AURKA encodes Aurora kinase A, a serine/threonine kinase involved in mitosis that acts as an oncogene when amplified or overexpressed. The gene discussed is MYCN; the disease is prostate cancer.